[8-K/A] ABVC BioPharma, Inc. Amends Material Event Report

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

8-K/A

Rhea-AI Filing Summary

Analyzing...

07/18/2025 - 05:04 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Abvc Biopharma Inc

NASDAQ:ABVC

ABVC Rankings

#9046 Ranked by Market Cap

N/A Ranked by Dividends

ABVC Latest News

Dec 19, 2024

ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21

Dec 11, 2024

ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners

Nov 14, 2024

ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones

Oct 22, 2024

ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners

Aug 15, 2024

ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements

ABVC Latest SEC Filings

Jul 15, 2025

[SCHEDULE 13D/A] ABVC BioPharma, Inc. SEC Filing

Jun 27, 2025

[S-8] ABVC BioPharma, Inc. Employee Benefit Plan Registration

ABVC Stock Data

Market Cap 56.89M

Float 14.01M

Insiders Ownership 21.95%

Institutions Ownership 3.89%

Short Percent 1.76%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City FREMONT